| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.FEBSLET.2015.08.034 |
| P698 | PubMed publication ID | 26341146 |
| P2093 | author name string | Tingting Li | |
| Wei Liu | |||
| Huaqiang Liu | |||
| Guoxing Xu | |||
| P2860 | cites work | Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains | Q24318185 |
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation | Q24658400 | ||
| The tumor suppressor microRNA let-7 represses the HMGA2 oncogene | Q24681392 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2 | Q28254493 | ||
| The epidemiology of osteosarcoma | Q34021577 | ||
| Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer | Q34347197 | ||
| MicroRNA Involvement in Osteosarcoma | Q35898407 | ||
| miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3) | Q36596220 | ||
| Oncogenic HMGA2: short or small? | Q36808432 | ||
| Roles of HMGA proteins in cancer | Q37001370 | ||
| Prognostic factors in localized extremity osteosarcoma: a systematic review | Q37397961 | ||
| MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects | Q38116793 | ||
| MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression | Q38893713 | ||
| Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. | Q38928834 | ||
| MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. | Q39033118 | ||
| miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
| High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma | Q40183414 | ||
| The effect of local recurrence on survival in resected osteosarcoma | Q44584457 | ||
| miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. | Q44656714 | ||
| miR-150 promotes the proliferation of lung cancer cells by targeting P53. | Q50926666 | ||
| P433 | issue | 20 Pt B | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 3148-3153 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma | |
| P478 | volume | 589 |
| Q28067107 | Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment |
| Q41348645 | Differentially expressed lncRNAs and miRNAs with associated ceRNA networks in aged mice with postoperative cognitive dysfunction. |
| Q96952948 | Down-Regulation of Ribosomal Protein RPS21 Inhibits Invasive Behavior of Osteosarcoma Cells Through the Inactivation of MAPK Pathway |
| Q41721808 | Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway |
| Q92626278 | Exosomal microRNA profiling in early and late onset preeclamptic pregnant women reflects pathophysiology |
| Q92921699 | High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network |
| Q49288145 | High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis |
| Q98778838 | Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma |
| Q90214717 | Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases |
| Q98944086 | Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p |
| Q52576042 | MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer. |
| Q37138386 | MicroRNA-490 inhibits tumorigenesis and progression in breast cancer. |
| Q92890196 | MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation |
| Q61453388 | MicroRNA-490-3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1 |
| Q28069353 | MicroRNAs for osteosarcoma in the mouse: a meta-analysis |
| Q92645419 | Potential targets and clinical value of miR-490-5p in hepatocellular carcinoma: a study based on TCGA, qRT-PCR and bioinformatics analyses |
| Q89422996 | TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals |
| Q49167671 | To Explore the Mechanism of the GRM4 Gene in Osteosarcoma by RNA Sequencing and Bioinformatics Approach. |
| Q38759546 | miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2. |
| Q61812186 | miR-16 regulates proliferation and apoptosis of pituitary adenoma cells by inhibiting HMGA2 |
| Q64975012 | miR-490-3p functions as a tumor suppressor in glioma by inhibiting high-mobility group AT-hook 2 expression. |
| Q36555180 | miR-490-5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA. |
Search more.